OPTIMIZATION OF THERAPY FOR GASTROESOPHAGEAL REFLUX DISEASE IN COMORBIDITY WITH FUNCTIONAL DYSPEPSIA

Authors

  • Mirvosit M. Karimov
  • Pulat S. Zufarov
  • Guzal N. Sobirova
  • Shahlo S. Aripdjanova
  • Dildora K. Karimova

Keywords:

gastroesophageal reflux disease, functional dyspepsia, proton pump inhibitors, prokinetics

Abstract

It has been shown that in patients with GERD and functional dyspepsia, the use of proton pump inhibitors leads to a decrease in heartburn and pain behind the sternum. However, symptoms such as regurgitation, belching, feeling of early satiety and heaviness after eating were stopped ineffectively. The inclusion in the treatment complex of the prokinetic domperidone at a dose of 10 mg 3 times a day contributed to a more effective regression of symptoms of impaired motility of the esophagus and stomach.

Downloads

Published

2023-06-03

How to Cite

Mirvosit M. Karimov, Pulat S. Zufarov, Guzal N. Sobirova, Shahlo S. Aripdjanova, & Dildora K. Karimova. (2023). OPTIMIZATION OF THERAPY FOR GASTROESOPHAGEAL REFLUX DISEASE IN COMORBIDITY WITH FUNCTIONAL DYSPEPSIA. Central Asian Journal of Medicine, (4), 77-84. Retrieved from https://mail.journals.tma.uz/index.php/cajm/article/view/530

Issue

Section

Articles

Most read articles by the same author(s)